- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03230799
Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery
May 10, 2022 updated by: Haotian Lin, Sun Yat-sen University
Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts
Previously, we have developed a minimal invasive lens surgery in the purpose of reduce post-operative complications of congenital cataract.
This prospective, randomized controlled study aims at comparing the prognosis of the minimal invasive lens surgery and the traditional cataract surgery for treating congenital cataracts.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Patients with congenital cataract that requires surgical intervention are enrolled.
Then the patients are assigned to two groups: Group I: the participants receive a minimal invasive lens surgery, while in Group II, the participants receive a traditional cataract surgery.
A secondary intraocular lens implantation is performed when the patient is two years old for both Group I and Group II.
Investigators then compare the visual acuity, incidence of high intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil abnormality between two groups, to evaluate and compare the prognosis of minimal invasive lens surgery and traditional cataract surgery for treating congenital cataracts.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Recruiting
- Zhongshan Ophthalmic Center,Sun Yat-sen U
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 1 month and 24 months
- Uncomplicated congenital cataract (≥ 3 mm central dense opacity) in one or both eyes with an intact non-fibrotic capsular bag
- Informed consent signed by a parent or legal guardian
Exclusion Criteria:
- confirmed or suspected hereditary cataract, including and not restricted to family history of congenital cataract
- Intraocular pressure >21 mmHg
- Preterm birth (<28 weeks)
- Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or systemic disease (congenital heart disease, ischemic encephalopathy)
- History of ocular diseases (any congenital eye diseases, such as, congenital cataract, congenital glaucoma, congenital aniridia) in the family
- History of ocular trauma
- Microcornea
- Persistent hyperplastic primary vitreous
- Rubella
- Lowe syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: traditional cataract surgery
Central anterior continuous capsulorhexis (5-6 mm)+ irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy(ACCC+ I/A + PCCC + Anti-vit)
|
ACCC+ I/A + PCCC + Anti-vit: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy
|
|
Experimental: minimal invasive lens surgery
Peripheral capsulorhexis opening (1.0-1.5 mm)+irrigation/aspiration
|
We decreased the size of the capsulorhexis opening to 1.0-1.5 mm in diameter.
Then we moved the location of the capsulorhexis to the peripheral area of the lens instead of the central area.
A 0.9 mm phacoemulsification probe was used to remove the lens contents and/or cortical opacities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Best correctied visual acuity
Time Frame: recorded at each follow-up to five years of age.
|
Determined with the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.
|
recorded at each follow-up to five years of age.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
High intra-ocular pressure
Time Frame: after lens removal to five years of age.
|
Determined with Tono-Pen tonometer at each follow-up
|
after lens removal to five years of age.
|
|
Visual axis opacification
Time Frame: after lens removal to five years of age.
|
Determined with slit-lamp photography at each follow-up
|
after lens removal to five years of age.
|
|
Bi-ocular visual function
Time Frame: performed when the patient is four years old and five years old.
|
Determined with synoptophore
|
performed when the patient is four years old and five years old.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 28, 2017
Primary Completion (Anticipated)
June 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
July 17, 2017
First Submitted That Met QC Criteria
July 24, 2017
First Posted (Actual)
July 26, 2017
Study Record Updates
Last Update Posted (Actual)
May 17, 2022
Last Update Submitted That Met QC Criteria
May 10, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCPMOH2017-China-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Cataract
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingCongenital Cataract
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityCompleted
-
yin ying zhaoCompletedCongenital CataractChina
-
Wenzhou Medical UniversityCompleted
-
Wenzhou Medical UniversityCompletedCongenital CataractChina
-
Wenzhou Medical UniversityUnknown
-
Bambino Gesù Hospital and Research InstituteCompletedCataract Congenital
-
Sun Yat-sen UniversityCompletedCongenital Cataract
-
St. Erik Eye HospitalUnknown
-
Sun Yat-sen UniversityMinistry of Health, ChinaCompleted
Clinical Trials on traditional cataract surgery
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingCataract | Cataract Bilateral | Cataract Surgery
-
Sun Yat-sen UniversityRecruitingCongenital CataractChina
-
University of Texas Southwestern Medical CenterCompletedIncipient Cataract | Senile Nuclear SclerosisUnited States
-
Sun Yat-sen UniversityUnknown
-
Zagazig UniversityCompleted
-
Iladevi Cataract and IOL Research CenterCompletedCataract Surgery | Shallow Anterior Chamber | PhacoemulsificationIndia
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
University of OklahomaCompletedPrimary Open Angle Glaucoma | Cataract | Pigmentary GlaucomaUnited States
-
Ziemer Ophthalmic Systems AGCompleted
-
Technolas Perfect Vision GmbHCompleted